![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RPL37 |
Gene summary for RPL37 |
![]() |
Gene information | Species | Human | Gene symbol | RPL37 | Gene ID | 6167 |
Gene name | ribosomal protein L37 | |
Gene Alias | L37 | |
Cytomap | 5p13.1 | |
Gene Type | protein-coding | GO ID | GO:0002181 | UniProtAcc | P61927 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6167 | RPL37 | GSM4909281 | Human | Breast | IDC | 7.82e-45 | -3.91e-01 | 0.21 |
6167 | RPL37 | GSM4909285 | Human | Breast | IDC | 6.66e-12 | -1.78e-01 | 0.21 |
6167 | RPL37 | GSM4909287 | Human | Breast | IDC | 4.50e-03 | 7.81e-02 | 0.2057 |
6167 | RPL37 | GSM4909291 | Human | Breast | IDC | 6.06e-18 | -3.36e-01 | 0.1753 |
6167 | RPL37 | GSM4909293 | Human | Breast | IDC | 7.05e-14 | 1.80e-01 | 0.1581 |
6167 | RPL37 | GSM4909294 | Human | Breast | IDC | 5.67e-09 | 1.29e-01 | 0.2022 |
6167 | RPL37 | GSM4909297 | Human | Breast | IDC | 8.53e-07 | -2.27e-01 | 0.1517 |
6167 | RPL37 | GSM4909298 | Human | Breast | IDC | 1.09e-06 | 1.35e-01 | 0.1551 |
6167 | RPL37 | GSM4909301 | Human | Breast | IDC | 3.37e-04 | -1.28e-01 | 0.1577 |
6167 | RPL37 | GSM4909302 | Human | Breast | IDC | 2.91e-07 | -2.19e-01 | 0.1545 |
6167 | RPL37 | GSM4909306 | Human | Breast | IDC | 4.95e-27 | -2.68e-01 | 0.1564 |
6167 | RPL37 | GSM4909307 | Human | Breast | IDC | 2.28e-08 | -1.47e-01 | 0.1569 |
6167 | RPL37 | GSM4909308 | Human | Breast | IDC | 1.05e-48 | -4.43e-01 | 0.158 |
6167 | RPL37 | GSM4909309 | Human | Breast | IDC | 7.14e-07 | -2.32e-01 | 0.0483 |
6167 | RPL37 | GSM4909312 | Human | Breast | IDC | 3.48e-04 | -1.32e-01 | 0.1552 |
6167 | RPL37 | GSM4909319 | Human | Breast | IDC | 5.74e-47 | -7.73e-01 | 0.1563 |
6167 | RPL37 | GSM4909321 | Human | Breast | IDC | 3.25e-11 | -2.26e-01 | 0.1559 |
6167 | RPL37 | brca1 | Human | Breast | Precancer | 1.17e-68 | -4.18e-01 | -0.0338 |
6167 | RPL37 | brca2 | Human | Breast | Precancer | 3.27e-22 | -2.11e-01 | -0.024 |
6167 | RPL37 | brca3 | Human | Breast | Precancer | 7.28e-16 | -1.70e-01 | -0.0263 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00021819 | Breast | Precancer | cytoplasmic translation | 80/1080 | 148/18723 | 1.59e-59 | 8.54e-56 | 80 |
GO:19033209 | Breast | Precancer | regulation of protein modification by small protein conjugation or removal | 38/1080 | 242/18723 | 1.71e-08 | 1.17e-06 | 38 |
GO:19033219 | Breast | Precancer | negative regulation of protein modification by small protein conjugation or removal | 21/1080 | 95/18723 | 8.09e-08 | 4.61e-06 | 21 |
GO:00313969 | Breast | Precancer | regulation of protein ubiquitination | 33/1080 | 210/18723 | 1.45e-07 | 7.82e-06 | 33 |
GO:00313979 | Breast | Precancer | negative regulation of protein ubiquitination | 19/1080 | 83/18723 | 1.85e-07 | 9.54e-06 | 19 |
GO:19017989 | Breast | Precancer | positive regulation of signal transduction by p53 class mediator | 10/1080 | 25/18723 | 5.77e-07 | 2.49e-05 | 10 |
GO:19017969 | Breast | Precancer | regulation of signal transduction by p53 class mediator | 19/1080 | 93/18723 | 1.20e-06 | 4.60e-05 | 19 |
GO:00723319 | Breast | Precancer | signal transduction by p53 class mediator | 26/1080 | 163/18723 | 2.23e-06 | 7.76e-05 | 26 |
GO:19046679 | Breast | Precancer | negative regulation of ubiquitin protein ligase activity | 6/1080 | 12/18723 | 2.48e-05 | 5.71e-04 | 6 |
GO:00514449 | Breast | Precancer | negative regulation of ubiquitin-protein transferase activity | 7/1080 | 19/18723 | 5.68e-05 | 1.17e-03 | 7 |
GO:19046668 | Breast | Precancer | regulation of ubiquitin protein ligase activity | 7/1080 | 23/18723 | 2.26e-04 | 3.42e-03 | 7 |
GO:00514386 | Breast | Precancer | regulation of ubiquitin-protein transferase activity | 10/1080 | 53/18723 | 7.88e-04 | 9.29e-03 | 10 |
GO:00513489 | Breast | Precancer | negative regulation of transferase activity | 27/1080 | 268/18723 | 3.49e-03 | 2.90e-02 | 27 |
GO:000218114 | Breast | IDC | cytoplasmic translation | 82/1434 | 148/18723 | 2.60e-52 | 1.48e-48 | 82 |
GO:190332014 | Breast | IDC | regulation of protein modification by small protein conjugation or removal | 43/1434 | 242/18723 | 1.71e-07 | 9.16e-06 | 43 |
GO:003139614 | Breast | IDC | regulation of protein ubiquitination | 37/1434 | 210/18723 | 1.50e-06 | 6.36e-05 | 37 |
GO:190332114 | Breast | IDC | negative regulation of protein modification by small protein conjugation or removal | 22/1434 | 95/18723 | 2.16e-06 | 8.69e-05 | 22 |
GO:007233114 | Breast | IDC | signal transduction by p53 class mediator | 30/1434 | 163/18723 | 5.82e-06 | 1.89e-04 | 30 |
GO:190179814 | Breast | IDC | positive regulation of signal transduction by p53 class mediator | 10/1434 | 25/18723 | 7.56e-06 | 2.27e-04 | 10 |
GO:003139714 | Breast | IDC | negative regulation of protein ubiquitination | 19/1434 | 83/18723 | 1.25e-05 | 3.29e-04 | 19 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa03010101 | Stomach | SIM | Ribosome | 62/465 | 167/8465 | 3.51e-36 | 1.07e-33 | 8.57e-34 | 62 |
hsa05171101 | Stomach | SIM | Coronavirus disease - COVID-19 | 65/465 | 232/8465 | 1.47e-29 | 2.23e-27 | 1.79e-27 | 65 |
hsa03010111 | Stomach | SIM | Ribosome | 62/465 | 167/8465 | 3.51e-36 | 1.07e-33 | 8.57e-34 | 62 |
hsa05171111 | Stomach | SIM | Coronavirus disease - COVID-19 | 65/465 | 232/8465 | 1.47e-29 | 2.23e-27 | 1.79e-27 | 65 |
Page: 1 2 3 4 5 6 7 8 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RPL37 | SNV | Missense_Mutation | c.113G>A | p.Gly38Asp | p.G38D | P61927 | protein_coding | deleterious(0.01) | probably_damaging(0.975) | TCGA-AG-3592-01 | Colorectum | rectum adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
RPL37 | SNV | Missense_Mutation | novel | c.118C>T | p.Pro40Ser | p.P40S | P61927 | protein_coding | deleterious(0.02) | possibly_damaging(0.828) | TCGA-A5-A1OH-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Chemotherapy | carboplatin | CR |
RPL37 | SNV | Missense_Mutation | novel | c.164G>T | p.Arg55Ile | p.R55I | P61927 | protein_coding | deleterious(0) | possibly_damaging(0.808) | TCGA-AJ-A3EK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
RPL37 | SNV | Missense_Mutation | c.203N>T | p.Lys68Ile | p.K68I | P61927 | protein_coding | deleterious(0) | possibly_damaging(0.866) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
RPL37 | SNV | Missense_Mutation | rs548862946 | c.265G>A | p.Ala89Thr | p.A89T | P61927 | protein_coding | tolerated(0.1) | benign(0.001) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
RPL37 | SNV | Missense_Mutation | c.17N>T | p.Ser6Leu | p.S6L | P61927 | protein_coding | deleterious(0.02) | benign(0.376) | TCGA-64-5781-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | cisplatin | PD | |
RPL37 | SNV | Missense_Mutation | novel | c.90G>C | p.Gln30His | p.Q30H | P61927 | protein_coding | deleterious(0.01) | benign(0.202) | TCGA-77-7465-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
RPL37 | SNV | Missense_Mutation | novel | c.19N>A | p.Ser7Thr | p.S7T | P61927 | protein_coding | deleterious(0.01) | probably_damaging(0.938) | TCGA-CN-6013-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | PD |
RPL37 | SNV | Missense_Mutation | c.152N>G | p.Ala51Gly | p.A51G | P61927 | protein_coding | tolerated(0.17) | benign(0.031) | TCGA-G9-6339-01 | Prostate | prostate adenocarcinoma | Male | <65 | 7 | Unknown | Unknown | PD | |
RPL37 | SNV | Missense_Mutation | c.25N>A | p.Gly9Arg | p.G9R | P61927 | protein_coding | deleterious(0.03) | benign(0.257) | TCGA-HU-A4G8-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Chemotherapy | 5-fluorouracil | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |